Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy women between 18 and 50 for the entire study, except women enrolled from India should be aged between 18 and 40 years, requesting contraception~* Smokers may not exceed 35 years of age~Exclusion Criteria:~* Pregnancy or lactation (delivery, abortion, or lactation within less than three cycles before the start of treatment)~* Body mass index (BMI) \> 32 kg/m2~* Any disease or condition that may worsen under hormonal treatment~* Undiagnosed abnormal genital bleeding~* Other contraceptive methods such as sterilization, hormonal contraception, IUD within 30 days of Visit 1, monthly contraceptive injection within a period of three times of the injection interval before start of treatment~* Any medication that could result in excessive accumulation, impaired metabolism, or altered excretion of the study drug or interfere with the conduct of the study or the interpretation of the results

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- EV/DNG (Qlaira, BAY86-5027) (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).